TINJAUAN SISTEMATIS EFEKTIVITAS LAYANAN TELEFARMASI OLEH APOTEKER TERHADAP HASIL KLINIS DAN KEPUASAN PASIEN

Authors

  • Abdur Rahman Program Magister Farmasi, Fakultas Farmasi, Universitas Surabaya, Indonesia
  • Adji Prayitno Setiadi Adji Departemen Farmasi Klinik dan Komunitas, Fakultas Farmasi, Universitas Surabaya, Indonesia https://orcid.org/0000-0002-7020-8216
  • Yosi Irawati Wibowo Yosi Departemen Farmasi Klinik dan Komunitas, Fakultas Farmasi, Universitas Surabaya, Indonesia

DOI:

https://doi.org/10.36387/jiis.v10i2.2570

Keywords:

Telepharmacy, Effectiveness, PRISMA 2020, Systematic review

Abstract

Telepharmacy is a rapidly expanding form of remote pharmaceutical care, especially since the COVID-19 pandemic, aimed at improving access to and the quality of pharmaceutical services. Despite its widespread implementation, the effectiveness of this service remains a topic of debate. Therefore, this study aims to evaluate the types and effectiveness of telepharmacy services provided by pharmacists through a systematic review. This study employed a systematic review approach following the PRISMA 2020 guidelines. Data sources were obtained from PubMed and Oxford Journal databases using relevant keywords such as ‘effectivity,’ ‘effectiveness,’ and ‘telepharmacy.’ The process involved study identification, screening, quality assessment, and data extraction, resulting in 24 articles that met the inclusion criteria. Telepharmacy services identified across the studies were categorized into four main types: 1) remote pharmacist consultation (n=10), 2) drug information provision (n=7), 3) therapeutic drug monitoring (n=5), and 4) electronic medication dispensing (n=2). Evaluation of telepharmacy effectiveness demonstrated significant improvements in several aspects, including: 1) clinical outcomes (6 out of 9 studies; p = 0.019–0.048), 2) patient satisfaction (3 out of 4 studies; p = 0.018–0.041), 3) medication adherence (12 out of 15 studies; p = 0.002–0.040), and 4) cost efficiency (all 4 studies; p = 0.021–0.048). The findings of this systematic review indicate that telepharmacy services are generally effective in improving patient clinical outcomes, patient satisfaction with services, medication adherence, and treatment cost efficiency.

Author Biographies

  • Abdur Rahman, Program Magister Farmasi, Fakultas Farmasi, Universitas Surabaya, Indonesia

    Graduate student, Master Program in Clinical Pharmacy, Universitas Surabaya

  • Adji Prayitno Setiadi Adji, Departemen Farmasi Klinik dan Komunitas, Fakultas Farmasi, Universitas Surabaya, Indonesia

    Lecturer, Faculty of Pharmacy, Universitas Surabaya

  • Yosi Irawati Wibowo Yosi, Departemen Farmasi Klinik dan Komunitas, Fakultas Farmasi, Universitas Surabaya, Indonesia

    Lecturer, Department of Pharmacy, Faculty of Pharmacy, Universitas Surabaya.

References

DAFTAR PUSTAKA

1. Mohamed Ibrahim O, Ibrahim RM, Abdel-Qader DH, Al Meslamani AZ, Al Mazrouei N. Evaluation of telepharmacy services in light of COVID-19. Telemed e-Health. 2021;27:649–56.

2. Park JY, Zed PJ, De Vera MA. Perspectives and experiences with telepharmacy among pharmacists in Canada: A cross-sectional survey. Pharm Pract (Granada). 2022;20(1).

3. Tjiptoatmadja NN, Alfian SD. Knowledge, perception, and willingness to use telepharmacy among the general population in Indonesia. Front Public Health. 2022;10:911394.

4. Singapore Pharmacy Council. Guidelines for Telepharmacy. Singapore: Singapore Pharmacy Council; 2009

5. Ritcher OZ, et al. Systematic Literature Reviews in Educational Research: Methodology, Perspectives, and Application. Wiesbaden: Springer VS; 2020.

6. Turcotte V, Chagnon A, Guénette L. Experience and perspectives of users and non-users of the Ask Your Pharmacist teleconsultation platform. Explor Res Clin Soc Pharm. 2021;2:100031.

7. Hefti E, Wei B, Engelen K. Access to telepharmacy services may reduce hospital admissions in outpatient populations during the COVID-19 pandemic. Telemed e-Health. 2022;28(9):1324–31.

8. Baldoni S, Amenta F, Ricci G. Telepharmacy services: Present status and future perspectives: A review. Medicina (Kaunas). 2019;55(7):1–12

9. Pathak S, Haynes M, Qato DM, Urick BY. Telepharmacy and quality of medication use in rural areas, 2013-2019. Prev Chronic Dis. 2020;17

10. Muhammad K, Baraka MA, Shah SS, Butt MH, Wali H, Saqlain M, et al. Exploring the perception and readiness of pharmacists towards telepharmacy implementation: A cross-sectional analysis. PeerJ. 2022;10.

11. Margusino-Framiñán L, Llamazares CMF, Negro-Vega E, Tortajada-Goitia B, Lizeaga G, Mercadal-Orfila G, et al. Outpatients’ opinion and experience regarding telepharmacy during the COVID-19 pandemic: The Enopex Project. J Multidiscip Healthc. 2021;14:3621–32.

12. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.

13. Institute of Medicine (IOM). Finding what works in health care: standards for systematic reviews. Washington, DC: The National Academies Press; 2011

14. Long H.A., French D.P., Brooks J.M. Optimising the value of the Critical Appraisal Skills Programme (CASP) tool for quality appraisal in qualitative evidence synthesis. Res Synth Methods. 2020;11(5):530–40

15. Unni EJ, Patel K, Beazer IR, Hung M. Telepharmacy during COVID-19: A scoping review. Pharmacy [Internet]. 2021;9(4):183. Available from: https://doi.org/10.3390/pharmacy9040183

16. Alfian SD, et al. Knowledge, perception, and willingness to provide telepharmacy services among pharmacy students: a multicenter cross-sectional study in Indonesia. BMC Med Educ. 2023;23:1–9.

17. Ameri A, Salmanizadeh F, Keshvardoost S, Bahaadinbeigy K. Investigating pharmacists’ views on telepharmacy: prioritizing key relationships, barriers, and benefits. J Pharm Technol. 2020;36:171–8.

18. Bazzari FH, Bazzari AH. Utilizing ChatGPT in telepharmacy. Cureus. 2024;16:1–26.

19. Bruns BE, Lorenzo-Castro SA, Hale GM. Controlling blood pressure during a pandemic: The impact of telepharmacy for primary care patients. J Pharm Pract. 2024;37:364–8.

20. Mohamed Ibrahim O, Ibrahim RM, Abdel-Qader DH, Al Meslamani AZ, Al Mazrouei N. Evaluation of telepharmacy services in light of COVID-19. Telemed e-Health. 2021;27:649–56.

21. Francis M, Francis P, Patanwala AE, Penm J. Obtaining medication histories via telepharmacy: an observational study. J Pharm Policy Pract. 2023;16:1–9

22. Ibrahim OM, Al Meslamani AZ, Ibrahim R, Kaloush R, Al Mazrouei N. The impact of telepharmacy on hypertension management in the United Arab Emirates. Pharm Pract (Granada). 2022;20:1–11.

23. Brown W, Scott D, Friesner D, Schmitz T. Impact of telepharmacy services as a way to increase access to asthma care. J Asthma. 2017;54:961–7.

24. Lertsinudom S, Tiamkao S, Mungmanitmongkol S, Dilokthornsakul P. Telepharmacy services to support patients with epilepsy in Thailand: A descriptive study. Heliyon. 2023;9:e13361.

25. Matsumoto Y, et al. Telepharmacy in mountainous depopulated areas of Japan: an exploratory interview study of patients’ perspectives. Drug Discov Ther. 2021;15:337–40.

26. Mozu IE, et al. Utilization of telepharmacy in the management of hypertension. Explor Res Clin Soc Pharm. 2023;12:100381.

27. Keeys C, et al. Pharmacist-managed inpatient discharge medication reconciliation: A combined onsite and telepharmacy model. Am J Health Syst Pharm. 2014;71:2159–66.

28. Omboni S, Tenti M. Telepharmacy for the management of cardiovascular patients in the community. Trends Cardiovasc Med. 2019;29:109–17. doi: 10.1016/j.tcm.2018.07.002.

29. Rebello KE, et al. The Rural PILL Program: A Postdischarge Telepharmacy Intervention for Rural Veterans. J Rural Health. 2017;33:332–9.

30. Al Ammari M, et al. Tele-pharmacy Anticoagulation Clinic During COVID-19 Pandemic: Patient Outcomes. Front Pharmacol. 2021;12:1–9.

31. Alarfaj SJ, et al. Comparing tele-pharmacy and standard clinic follow-up for newly initiated warfarin anticoagulation therapy: A retrospective study. Saudi Med J. 2024;45:1374–82.

32. Alsultan MM, et al. Knowledge and Perception of Pharmacy Students toward Telepharmacy Education in Saudi Arabia. Healthcare. 2024;12:1806.

33. Carandang RR, Ancheta YM, Beleno G, Gonzales AM, Longaza NI. “I’m not very skilled in using gadgets:” A qualitative exploration of the facilitators and barriers to using telepharmacy services among Filipino senior citizens. Explor Res Clin Soc Pharm. 2024;15:100477.

34. Jirjees F, et al. The rise of telepharmacy services during the COVID-19 pandemic: A comprehensive assessment of services in the United Arab Emirates. Pharm Pract (Granada). 2022;20:1–11.

35. Lopez SE, Lim RXT. Comparing the effectiveness, safety and cost of teleconsultation versus face-to-face model of pharmacist-led anticoagulation clinic: A single institution experience. Ann Acad Med Singap. 2024;53:334–7.

36. Manuel FC, Wieruszewski ED, Brown CS, Russi CS, Mattson AE. Description of telepharmacy services by emergency medicine pharmacists. Am J Health Syst Pharm. 2022;79(11):873–80.

37. Deas C, Stockton K. Evaluation of outcomes of a pharmacist-run, outpatient insulin titration telepharmacy service. Innov Pharm. 2019;10(5).

38. Butler, A., Hall, H. & Copnell, B., 2016. A guide to writing a qualitative systematic review protocol to enhance evidence-based practice in nursing and health care. Worldviews on Evidence-Based Nursing, 13(3), pp.241–249.

39. Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: A meta-analysis. Med Care. 2009;47(8):826-834.

Published

2025-10-31

How to Cite

TINJAUAN SISTEMATIS EFEKTIVITAS LAYANAN TELEFARMASI OLEH APOTEKER TERHADAP HASIL KLINIS DAN KEPUASAN PASIEN. (2025). JIIS (Jurnal Ilmiah Ibnu Sina): Ilmu Farmasi Dan Kesehatan, 10(2), 127-140. https://doi.org/10.36387/jiis.v10i2.2570

Similar Articles

1-10 of 29

You may also start an advanced similarity search for this article.